Literature DB >> 12944699

Nasoethmoidal meningioma with cytogenetic features of tumor aggressiveness in a 16-year-old child.

Ralf Ketter1, Wolfram Henn, Wolfgang Feiden, Alexandra Prowald, Christian Sittel, Wolf-Ingo Steudel, Martin Strowitzki.   

Abstract

The case of a 16-year-old girl is presented who was admitted to our hospital because of severe frontal headache. Magnetic resonance scans revealed a nasoethmoidal tumor on the right side, with erosion of the skull base and invasion of the right orbit. A needle biopsy specimen revealed the histological diagnosis of a fibroblastic meningioma (WHO grade II), with histochemically determined partial activity loss of alkaline phosphatase. The tumor was completely resected by a combined intracranial-transbasal and transnasal approach. In this case, we found a meningioma with deletion of the short arm of chromosome 1 through a translocation between chromosomes 1 and 11 [t(1;11)] as well as additional chromosomal aberrations, including partial or complete monosomy of chromosomes 2, 6, 7, 11, 13 and 22, a cytogenetic pattern known to be associated with elevated tumor aggressiveness in meningiomas of adult patients. Accordingly, this juvenile meningioma may biologically correspond to a WHO grade II adult-type meningioma with an increased risk of recurrence. Therefore, we incorporated this patient into an intensified schedule of postoperative care. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2003        PMID: 12944699     DOI: 10.1159/000072470

Source DB:  PubMed          Journal:  Pediatr Neurosurg        ISSN: 1016-2291            Impact factor:   1.162


  2 in total

1.  A rare case of primary nasoethmoidal meningioma.

Authors:  J K Sharma; S K Pippal; Yatin Sethi
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2006-01

2.  Ectopic meningioma in the bilateral nasal olfactory cleft: A case report and literature review.

Authors:  Y I Zhang; Wei-Qiang Teng; Xiao-Ping Chen; Jian Wu
Journal:  Oncol Lett       Date:  2015-02-17       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.